NEWS, EVENTS, and DEADLINES

June 27, 2023

Meet the 3rd Cohort of NJ ACTS KL2 Awardees

KL2 Mentored Career Development Award


On behalf of the Early Career Development Program (KL2) we are delighted to announce they have welcomed four new scholars into the program. Led by Sally Radovick, MD, the KL2 is a Mentored Career Development Award. The award is designed to support junior faculty in the translational sciences supported by NJ ACTS. Welcome and congratulations to our new scholars.


NJ ACTS KL2 Scholars 2023-2025

Elisa Kallioniemi, PhD

Elisa Kallioniemi, PhD, Assistant Professor

New Jersey Institute of Technology


Mentor: Sergei Adamovich, PhD, Professor

Biomedical Engineering, New Jersey Institute of Technology


Project: Brain stimulation/neurophysiological methods


Kristine Schmitz, MD, FAAP, Assistant Professor

Rutgers Robert Wood Johnson Medical School


Mentor: Nancy E. Reichman, PhD, Professor 

Department of Pediatrics, RWJMS

Co-Mentor: Lawrence Kleinman, MD, MPH, Professor

and Vice Chair for Academic Development,

Department of Pediatrics, RWJMS


Project: Father's mental health and

their children's health and development

Kristine Schmitz, MD, FAAP

Yingci Liu, DDS, MS

Yingci Liu, DDS, MS, Assistant Professor

Rutgers School of Dental Medicine


Mentor: David Foran, PhD, Professor

Department of Pathology,

Laboratory Medicine and Radiology, RWJMS


Project: A deep learning approach to predicting disease progression in oral dysplasia and early-stage malignancy


Anthony Deo, MD, PhD, Assistant Professor

Rutgers Robert Wood Johnson Medical School


Mentor: Carlos Pato, MD, PhD, Professor and Executive Chair

Department of Psychiatry, RWJMS

Co-Mentor: David Zald, PhD, Henry Rutgers Term Professor

Department of Psychiatry, RWJMS


Project: Utilizing natural language processing to identify language biomarkers unique to childhood onset psychosis

Anthony Deo, MD, PhD

Questions? Please email Ms. Tracey Sharp, Program Administrator.

NJ ACTS in the News

Post-Doc Kimberly Wiersielis Awarded K99/R00 NIH Grant


Dr. Wiersielis, a postdoctoral fellow in the Department of Animal Sciences, is the recipient of an NIH Pathway to Independence Award that supports outstanding postdoctoral researchers in completing needed mentored training and transition in a timely manner to independent, tenure-track or equivalent faculty positions. Read More.


Wiersielis’ experience with writing grants began in 2019 when invited to attend the Grant Training Center: Professional Grant Development Workshop at Rutgers University. This initial interest then led Wiersielis to the NRMN-CAN grant writing group run in part by Dr. Lauren Aleksunes, the Workforce Development Core Lead for the NJ Alliance for Clinical and Translational Sciences (NJ ACTS). Read More about NJ ACTS Grant Writing Training Programs.

Community-Based Population Health Research


Earlier this year, Princeton University's ProCES (Program for Community Engaged Scholarship) partnered with NJ ACTS on an NIH grant-funded opportunity that connected five Princeton students with four community-partners working on community-engaged population health research projects:



Read the Full Article

Upcoming NJ ACTS, Rutgers, Princeton and NJIT Events

Program session dates: 

July 24, July 26, August 2, August 16

4:30pm - 7:30pm online


Through this program I-Corps provides training and grants to support team-based customer research aimed at investigating the viability and societal impact of scientific and technological discoveries.

Register Here

July 31, 2023

11:30 am - 1:30 pm*


EOHSI, Busch Campus,

Piscataway, NJ


*View Flyer

Register by July 25th!

NJ ACTS Workforce Development Core

NIH Grant Writing Fellowship

Application Workshop


Where Should I Start?

Building a Research Fellowship Application


Participants will learn the basics about constructing a NIH NRSA fellowship application with a focus on specific aims and will have top priority to join the 10-week fellowship writing group in Fall 2023.


Students/postdocs do not need to be affiliated with Rutgers to participate in this workshop. 


Team Science Across the NJ ACTS Consortium

Workshop Series Video

New Jersey Population Health Cohort Study


The newest video in the series highlights the New Jersey Population Health Cohort Study, which was launched in 2022 to improve understanding of how life events and stress affect health, particularly within historically disadvantaged groups, multigenerational families, and immigrant groups. The overarching goal of the study is to offer practical, actionable information for improving population health, well-being & health equity in New Jersey and beyond. 


The study is led by Joel C. Cantor, ScD, director of the Institute for Health’s Center for State Health Policy (CSHP). Speakers include Dr. Cantor, Dr. William Hu (RWJMS, IFH), and Margaret Koller (CSHP).

Team Science Across the NJ ACTS Consortium Workshop Series

Build a Successful Team! Team Science offers project-specific and general consultations on building and maintaining a successful research team and collaboration.

Request a Consultation

NJ ACTS Services

Join the Clinical Research Investigator Registry


The purpose of this registry is to match investigators with potential clinical trial opportunities that we are informed of through our industry and academic partnerships.

Register Here

Learn More about the Clinical Trials Office

The Princeton Pulse Podcast

Which Country Will Be the First to Wipe Out Cervical Cancer?


The latest episode of The Princeton Pulse Podcast highlights a potential win in the fight against cervical cancer – one that comes from a place that you might not expect. Rwanda, a low-income country, could become the first country in the world to eradicate the disease.


Available on the CHW websiteApple PodcastsSpotify, and other podcast platforms.

CTSA News and Events

NCATS, NIH, and Federal News and Events

White House Recognizes N3C as Largest US

Limited-dataset Using Privacy-preserving Analytics


The White House Office of Science and Technology Policy (OSTP) has released comprehensive recommendations to promote user data privacy for public and private entities. One of the key technical approaches outlined in the strategy is privacy-preserving record linkage (PPRL), which allows secure, private linkage of individual data across different datasets. The strategy highlights the National COVID Cohort Collaborative (N3C) as a prime example of PPRL implementation, harmonizing over 19 million patient-level records while ensuring the protection of sensitive data. Read More

Introducing... Ansible Podcasts!


Check out the inaugural episode of the Lab to Life podcast from the University of California Irvine to hear host Dr. Dan Cooper, Professor of Pediatrics and the director of the Institute for Clinical and Translational Science, discuss the difference between translational science and translational research – and much more.



NJ ACTS Publications

Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients. Crystal S, Nowels M, Samples H, Olfson M, Williams AR, Treitler P. Drug Alcohol Depend. 2022Mar1;232:109269. 


Psychosocial and behavioral therapy in conjunction with medication for opioid use disorder: Patterns, predictors, and association with buprenorphine treatment outcomes. Samples, Hillary; Williams, Arthur Robin; Crystal, Stephen; Olfson, Mark. Journal Of Substance Abuse Treatment. 2022 Aug;139:108774.

Click Here for More NJ ACTS Publications
In Case You Missed IT

The National Institutes of Health's All of Us Research Program has expanded its data to include nearly a quarter million whole genome sequences for broad research use. Read more!

Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) $175M 2023 Appropriation - For fiscal year 2023 TBIPHRP is offering a range of mechanisms to accommodate research across the development spectrum. See Flyer for Details

View NJ ACTS Services
Sign Up to Receive the NJ ACTS Newsletter
Click Here for NJ ACTS Newsletter Archive

NJ ACTS is a partnership between Rutgers, NJIT and Princeton. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.

Components
Visit NJ ACTS
View NJ ACTS Calendar
Connect with us
Facebook  Twitter  Youtube  LinkedIn
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number, UL1TR003017 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
 
New Jersey Alliance for Clinical and Translational Science
89 French St., Suite 4211
New Brunswick, NJ
 
Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved
 
Send story ideas to NJACTS@rbhs.rutgers.edu
 
UL1TR003017, KL2TR003018 and TL1TR003019